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Abstract
Background: Self-tests can be used by members of the public to diagnose conditions without
involving a doctor, nurse or other health professional. As technologies to design and manufacture
diagnostic tests have developed, a range of self-tests have become available to the public to buy
over-the-counter and via the Internet. This study aims to describe how many people have used self-
tests and identify factors associated with their use.
Methods:  A postal questionnaire will elicit basic information, including sociodemographic
characteristics, and whether the person has used or would use specified self-tests. Consent will be
sought to recontact people who want to participate further in the study, and interviews and focus
groups will be used to develop hypotheses about factors associated with self-test use. These
hypotheses will be tested in a case-control study. An in-depth questionnaire will be developed
incorporating the identified factors. This will be sent to: people who have used a self-test (cases);
people who have not used a self-test but would use one in the future (controls); and people who
have not used and would not use a self-test (controls). Logistic regression analysis will be used to
establish which factors are associated with self-test use.
Discussion: Self-tests do have potential benefits, for example privacy and convenience, but also
potential harms, for example delay seeking treatment after a true negative result when the
symptoms are actually due to another condition. It is anticipated that the outcomes from this study
will include recommendations about how to improve the appropriate use of self-tests and existing
health services, as well as information to prepare health professionals for patients who have used
self-tests.
Background
Members of the public have become more involved in
their own care. They use pregnancy tests and tests to mon-
itor diagnosed conditions, such as diabetes mellitus [1],
and self blood pressure measurement is popular [2]. Initi-
atives such as NHS Direct and the need to control costs
have contributed to the development of self-care [3,4], as
highlighted by the increasing scope for self-medication
[5]. While this has been happening, technologies to
design and manufacture tests that can be used in the home
have advanced. As a result, a wider range of diagnostic and
screening tests have become available to the general pub-
lic [6]. These include tests for chlamydia, prostate specific
antigen and faecal occult blood. Results are available
immediately or after sending a sample to a laboratory, but
contact with a doctor, nurse or other health professional
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is not necessary. These "self-tests" are likely to become
even more easily available and widely used as the Internet
continues to reduce physical and intellectual barriers.
People may use self-tests because of benefits of being
tested outside a conventional medical setting. For exam-
ple, people who would not visit a health professional may
screen themselves because it is more convenient and pri-
vate [7]. There are, however, also potential harms from
being tested in this way. For example, a person who
receives results without an interpretation of the whole pic-
ture, including signs and symptoms, could think he/she
has a disease inappropriately, or a person could delay
seeking treatment after a true negative result when his/her
symptoms are actually due to another condition. There
will also be false positive and false negative results. Self-
tests are used without a formal independent assessment of
these harms and benefits. Even if members of the public
use tests that have been assessed as being beneficial when
used during conventional screening programmes, their
use is outside those quality assured programmes. Possible
doubts associated with such testing include test accuracy,
that people who are most at risk may not use self-tests,
and that people with positive results may not actually get
treated [8].
Many general practitioners feel that their workload has
grown due to the move towards a primary-care-led NHS,
that their prescribing behaviour is affected by patient
demand, and that the number of demanding patients has
risen [9-11]. An expansion of the use of self-tests may also
exacerbate this perceived increase in demand and work-
load as people seek an explanation of results or further
investigation.
Despite the potential impact of self-tests, the extent of
their use is not known. Other than market research, a
comprehensive literature review identified only one
recent survey in the United Kingdom that asked partici-
pants about whether they had used home testing kits, and
this was part of a study on attitudes to genetic testing [12].
There is also an absence of studies about why people use
self-tests and perceived and actual harms and benefits.
Pilot work
During September and October 2004, we sent question-
naires and prepaid envelopes to 380 addresses randomly
selected from the Birmingham South West 2004/05 resi-
dential telephone directory. The questionnaire asked
whether the respondent had used or would use specified
self-tests, with room to add any not listed. We wanted to
maximise responses from men and women because some
self-tests, for example for prostate disorders, would only
be used by one sex. We, therefore, sent two questionnaires
to each address with a request for the addressee to give the
additional questionnaire to any other adult living at the
same address. The questionnaire asked whether the
respondent lived alone to allow us to estimate the denom-
inator.
Three questionnaires were returned because the addressee
had died or moved, and 184 completed questionnaires
were received from the remaining 377 households. The
denominator for the response rate (n = 697) was esti-
mated as the 57 respondents who reported that they lived
alone plus two adults at each of the remaining 320
addresses, and the response rate was 26%. Excluding 22
people who had only used a pregnancy test, 28 (15%)
respondents said they had used a self-test. Respondents
most commonly reported using a test for diabetes (n =
18), but they also reported using tests for cholesterol,
infertility, urinary infection, haematuria, prostate specific
antigen and HIV-infection. Sixty two percent (n = 96) of
the 154 respondents who had not used a self-test other
than a pregnancy test said they would use one in the
future.
Study aims
The primary aims of this study are to describe the preva-
lence of the use of self-tests by members of the public to
diagnose or screen for conditions without the involve-
ment of a doctor, nurse or other health professional, and
to determine factors that are associated with their use.
Methods
Study design
Mixed methods two-stage study with (1) an initial survey
comprising a postal questionnaire, interviews and focus
groups, followed by (2) an embedded case-control study.
Selection criteria
Adults aged 18 years or older randomly selected from par-
ticipating general practices will be asked to complete the
initial questionnaire. Practices will be selected to reflect
the diversity of the population based on deprivation indi-
cators, population density and ethnicity.
Exclusion criteria
The initial questionnaire will not be sent to people who
the general practitioner feels that it would be inappropri-
ate to approach, for example people with a severe mental
illness, terminal illness or recent bereavement.
Methods of data collection
The initial survey involves a postal questionnaire that will
elicit basic information about sociodemographic charac-
teristics (e.g. age, sex, ethnic group, employment status),
health status, and whether the person has used or would
use self-tests that have been identified as available from a
search of the Internet. The questionnaire will be designedBMC Public Health 2006, 6:193 http://www.biomedcentral.com/1471-2458/6/193
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using lessons learnt from the pilot survey and will be
piloted with a small sample of the target population
before being widely distributed. A cover letter will outline
the study in lay terms and ask people to complete the
questionnaire and return it in the enclosed prepaid enve-
lope. The letter will be on headed notepaper from the per-
son's general practice and signed by a partner at the
practice. People will be given the option of returning a
blank questionnaire to indicate that they do not want to
take part. One reminder will be sent to non-responders.
This first questionnaire will seek consent for recontacting
people about further participation in the study.
Interviews are suitable for gaining an in-depth under-
standing of personal experience and perspectives [13],
and we will use interviews to investigate factors that may
have influenced whether people used self-tests. Focus
groups can be used to pilot ideas and questions [14,15],
and we will conduct focus groups with people who have
not used self-tests to reflect on the general applicability of
factors identified in the interviews. People who consented
to be recontacted about talking with a researcher will be
sent an information leaflet and a reply slip to indicate if
they would like to take part in an interview or focus group
with a prepaid envelope to return the slip. To put people
at ease and increase the likelihood of interaction, focus
groups will include people of the same sex and similar
ages. A semi-structured topic guide will be used for the
interviews, and the topic guide for the focus groups will be
based on factors identified during the interviews.
Results from the postal questionnaire, interviews and
focus groups will be used to develop hypotheses about
factors that may influence use of self-tests other than preg-
nancy tests: pregnancy tests will be excluded as women
have used them for some time and their use is probably
now expected by doctors. These hypotheses will then be
tested in a case-control study. An in-depth questionnaire
will be developed incorporating the factors of interest. The
questionnaire will be piloted with a small number of peo-
ple from the target groups before it is sent to: cases who
have used a self-test; controls who have not used a self-test
but would use one in the future; and controls who have
not used a self-test and would not use one in the future.
This staging of questionnaires has been successfully used
in other studies and is believed to generate a better
response rate then sending a longer initial questionnaire
[16]. A cover letter will outline the study in lay terms and
ask people to consider completing the questionnaire and
returning it using the enclosed prepaid envelope. People
will be given the option of returning a blank question-
naire to indicate that they do not want to take part. One
reminder will be sent to people who do not return a ques-
tionnaire.
Justification of sample size
As pregnancy tests will be excluded, self-test in this and
the next section refers to tests other than pregnancy tests.
Conservatively assuming that 10% of people have used a
self-test, a sample of 4200 people will allow estimation of
the prevalence of the use of self-tests with at least +/-1%
precision and 95% confidence. Based on a response rate
of 40%, which is less than other large prevalence surveys
[16], the questionnaire will be sent to 10500 people.
Assuming an average list size of 4500 people, 75% of
whom are 18 years or older [17], and 5% of whom meet
the exclusion criteria, it would be sufficient to recruit four
general practices, but up to eight will be recruited to reflect
diversity and increase generalisability.
It is assumed that 75% (n = 315) of the 420 respondents
who have used a self-test and 50% (n = 1890) of the 3780
respondents who have not used a self-test will agree to be
recontacted. Purposive sampling will be used to select
people for interviews and focus groups [18]. For the inter-
views, we will select men and women of different ages
(younger and older) who have used self-tests for different
conditions (cancers, other chronic conditions, sexually
transmitted infections, other acute infections or condi-
tions). The ideal size for a focus group is between four and
eight people [15], and we anticipate that each group will
include six people who have not used self-tests. To facili-
tate sharing of views [14], we will hold groups with people
of the same sex and similar ages. To allow loose matching
by age (younger or older) and sex (male or female), up to
four groups will be held. We anticipate, therefore, that
interviews and focus groups will involve up to about 24
self-test users and 24 non-users [19].
Assuming that 75% of people who have used a self-test
and 50% of people who have not used a self-test respond
to the invitation to take part in an interview or focus
group, we will need to approach 32 people who have used
a self-test and 48 people who have not used a self-test to
take part in this part of the study. This will leave 283 self-
test users and 1842 non-users who have agreed to be
recontacted.
In the absence of data relating to self-testing, we used fac-
tors associated with self-care to calculate a likely sample
size for the case-control study. A Spanish study found that
self-medication was more prevalent among people who
lived alone [20]. About 15% of adults aged 16 years or
over live alone [21,22]. If the same proportion of people
who have not used a self-test live alone, data from 207
cases and 207 controls should detect a doubling of the
odds of living alone among people who have used a self-
test with 80% power and 5% significance.BMC Public Health 2006, 6:193 http://www.biomedcentral.com/1471-2458/6/193
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Assuming that 75% of the remaining 283 self-test users
return the in-depth questionnaire, there will be data from
212 cases. The pilot survey suggests that 62% (n = 1148)
of the remaining 1842 non-users would consider using a
self-test in the future, whereas 38% (n = 694) would have
no interest in using one. Assuming a response rate of 50%,
the in-depth questionnaire will need to be sent to 424
people from each of these groups to generate 212 controls
from each group.
Methods of data analysis
The prevalence of the use of self-tests will be estimated
after appropriate standardisation to the national popula-
tion, and 95% confidence intervals will be calculated. We
will compare sociodemographic characteristics of people
who have used, who have not used, who would use, and
who would not use self-tests.
Interviews and focus groups will be recorded and fully
transcribed. The transcripts will be read, coded, indexed
and categorised, facilitated by appropriate software. We
will use grounded theory, that is we will identify analytical
categories as they emerge from the data and use these cat-
egories to develop hypotheses about factors that may be
associated with using self-tests [23]. The analysis will be
iterative: hypotheses will be tested as they emerge using
analytic induction [23], and we will amend the antici-
pated number of interviews and focus groups depending
upon whether new issues continue to emerge. Respondent
validation will be sought by inviting feedback from partic-
ipants who will be sent a written summary of the inter-
view or focus group.
The data from the second in-depth questionnaire will be
fully investigated and described using univariate and
bivariate comparisons of people who have and who have
not used a self-test. Stepwise logistic regression will then
be used to test the hypotheses developed during the inter-
views and focus groups and examined by the second ques-
tionnaire, and to establish those factors that are associated
with using a self-test.
Self-tests can be grouped according to the disease area, for
example for cancer or sexually transmitted infections. Sec-
ondary analyses will be conducted to generate hypotheses
about whether particular determinants of self-test use vary
by the type of test and, therefore, whether future research
should be test-specific.
Bias and confounding
We aim to maximise compliance and minimise selection
bias by keeping the demands on people to a minimum,
but we will compare the characteristics of responders and
non-responders and standardise the results to the
national population. People who have participated in
interviews or focus groups will be excluded from the case-
control study as their responses could be affected by the
discussion. During the case-control study, it is anticipated
that cases and controls will be matched by sex and age
group because they may be confounders: possible deter-
minants of self-test use, such as access to the Internet, may
vary with age. The criteria for matching will, however, be
finalised after further information is collected during the
interviews and focus groups. As the first questionnaire
may "educate" people and lead to self-test use, the second
questionnaire will be analysed on the basis of reported
self-test use when the first questionnaire was distributed.
To minimise recall bias, respondents to the second ques-
tionnaire will be asked to report behaviours and experi-
ences over the preceding year.
Ethical approval
This study has been approved by Solihull Local Research
Ethics Committee, reference 05/Q2706/13.
Discussion
The pilot study suggests that some people are using self-
tests. These findings are in line with a 1993 survey in
which 18% of respondents said they would prefer self-
testing to testing by a doctor [24]. A recent British Medical
Association report highlighted, however, that ad hoc
screening can put people at risk because of a lack of evi-
dence underpinning tests and insufficient quality assur-
ance and accompanying information [25]. Self-tests do
have potential benefits, for example privacy and conven-
ience, but also potential harms, for example distress
caused by false positive results [26]. Other potential prob-
lems include extra pressure on primary health care profes-
sionals and NHS laboratories as people seek an
explanation of results or further investigation [27].
Despite this, there is an absence of studies about self-tests.
We think that important first steps are to describe the
prevalence of the use of self-tests and to determine factors
that are associated with using them.
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